阅读说明：本技术 化合物的制剂及其用途 (Formulations of compounds and uses thereof ) 是由 B.柯比 S.S.米歇尔 C.H.纳尔逊 H-W.施 于 2020-03-09 设计创作，主要内容包括：本公开内容涉及FXR激动剂的制剂(例如片剂)及其治疗用途。本公开内容还涉及获得此类制剂的方法。(The present disclosure relates to formulations (e.g., tablets) of FXR agonists and therapeutic uses thereof. The disclosure also relates to methods of obtaining such formulations.)